NewsRx

Search our medical news database

Medical Verdicts and Law Weekly

Susan Hasty, Publisher

Table of Contents . . . January 19th, 2006

Non-Subscriber - Summaries Only

Related Areas: Other Issues in Medical Verdicts and Law Weekly | Other Publications

Alethia BioTherapeutics, Inc. - Patent application filed for bone-related validated targets

Alliance for Stem Cell Research - Stem cell research organization endorses proposed Missouri initiative

BioCryst Pharmaceuticals, Inc. - Hart-Scott-Rodino waiting period terminated early for the Roche license of BCX-4208

Cellectis SA - License agreement signed with AstraZeneca covering the use of homologous recombination

Cellectricon - Systems launched for adherent cell electroporation

Cepheid - New patents awarded for ultrasonic lysis and sample preparation technology

Collaborations - American Healthways to provide disease management services to BCBS Northern Plains Alliance

Community Bank, N.A. - Health savings accounts become more available

Competitive Technologies - Homocysteine assay license granted to Genzyme Diagnostics

CuresNow - Missouri Stem Cell Research and Cures Initiative gets solid endorsement

Cutting Edge Information - Blockbuster drugs' market share in danger

Diomed Holdings, Inc. - AngioDynamics and Vascular Solutions face motion for summary judgment

Drug Importation - Study shows Canadian drugs are more affordable than Medicare Part D

Federated Ambulatory Surgery Association - HHS Secretary and Senator Crapo lauded for commitment to expand access to ASCs

Frost & Sullivan Media - Patent expiry offers exciting growth opportunities

- Increasing number of coronary artery bypass grafts for women may result in burdensome cost

Aastrom Biosciences, Inc. - Positive human jaw bone reconstruction results reported from feasibility clinical trial

Abbott - ATLAS study shows improvement in quality of life for ankylosing spondylitis patients taking Humira

Abiomed, Inc. - Daniel Sutherby named chief financial officer at cardiac device company

Acologix, Inc. - Bone and kidney disease-focused company closes $25M series C financing

Actavis Group - Generic pharmaceutical firm completes acquisition of Alpharma's human generics business

Advanced Biotherapy, Inc. - Arthritis drug developer appoints Daniel Levitt to scientific advisory board

Advanced Chemistry Development, Inc. - Firms announce availability of Metabolite Database for labs

Advocate Christ Medical Center, Oak Lawn - Pelvic organ prolapse in women leads to reduced expression of lysyl oxidase

Affymetrix, Inc. - SNP panels launched for targeted genotyping applications

All Children's Hospital, St. Petersburg - Ex vivo system promotes stem-like cell trafficking from ventricles to culture surface

All India Institute of Medical Sciences - Latex of Calotropis procera was comparable to glibenclamide as antidiabetic agent

American Chemistry Council - Chemical makers work with Congress on security legislation

American Society for Aesthetic Plastic Surgery - Cosmetic plastic surgery predictions for 2006 issued

Amgen - Metabolism-focused biotech company to acquire Abgenix for $2.2 billion

Amylin Pharmaceuticals, Inc. - James Gavin elected to board of directors at company developing diabetes therapies

Anachem - Collaboration will bring new line of membrane technology products to U.K. and Ireland

Anachem - Medical device company expands range of serological pipettes

Anadys Pharmaceuticals, Inc. - Two executive advances reported at pharmaceutical firm developing hepatitis therapy

AngioDynamics, Inc. - New catheter launched to percutaneously drain abscesses

Anxiety Disorders - Association presents guidelines for the diagnosis and treatment of anxiety

Astellas Pharma U.S., Inc. - U.S. subsidiary of Japanese pharma firm appoints new R&D head

Australia Commonwealth Scientific & Industrial Research Org. - Weight loss did not improve flow-mediated dilatation

Avalon Pharmaceuticals, Inc. - Avalon Pharmaceuticals announces expiration of the sanofi-aventis agreement

Axis-Shield - Agreement signed to develop market tests on Abbott's Architect System

BTE Technologies, Inc. - New multi-cervical unit device launched for neck pain

Bayer Pharmaceuticals Corp. - Phase III study of Trasylol in elective spinal fusion surgery launched

Best Practices, LLC - Research shows forward-looking companies build organizational capabilities to manage speakers

Boston University - Higher doses of cidofovir may be safe to treat recurrent respiratory papillomatosis

Boston University - Hypoxia suppresses elastin repair in rat lung fibroblasts

Boston University - Researchers' findings advance Obesity Pathogenesis research

Brighton & Sussex University Hospital - HIV infection significantly reduces survival rate of patients with tuberculous meningitis

Brighton University - Gender differences in response to lorazepam treatment reported

Burnham Institute, La Jolla - Reports advance knowledge in HIV/AIDS Pathogenesis research

CalbaTech, Inc. - Solana MedSpas reaches agreement to exclusively offer LifeStem's stem cell microbank service

Cambrex Corporation - Dowpharma contracts first partner for use of Pfenex expression technology

Canberra Hospital - NSE and S100B levels correlated with hypoxia outcome in neonatal pigs

Cancer Therapy - Dendritic cell therapy arrests carbonic anhydrase II activity in tumor vessels

Candela Corporation - Intense pulsed light system gets FDA clearance

Capital University of Medical Science, Beijing - Diffusion tensor tractography used for neurosurgical planning

Caprion Pharmaceuticals Inc. - Antibodies win European and U.S. orphan drug status

Cardiff Research Consortium - Orlistat appeared to reduce need for additional diabetes drugs regardless of weight loss

Cardiology - Heartfelt wake-up call sounded for heart attack survivors

Catholic University, Rome - Low 25(OH)D does not affect insulin sensitivity in obesity after bariatric surgery

CeNeRx BioPharma, Inc. - Central nervous system-focused biopharma firm appoints chief medical officer

Celerus Diagnostics - Cancer diagnostics company completes initial financing round

Return to Top of Page

NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook